First Time Loading...

Inari Medical Inc
NASDAQ:NARI

Watchlist Manager
Inari Medical Inc Logo
Inari Medical Inc
NASDAQ:NARI
Watchlist
Price: 41.6 USD 11.41% Market Closed
Updated: May 2, 2024
Section:
 

Relative Value

The Relative Value of one NARI stock under the Base Case scenario is 43.48 USD. Compared to the current market price of 41.6 USD, Inari Medical Inc is Undervalued by 4%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

NARI Relative Value
Base Case
43.48 USD
Undervaluation 4%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

4.9
P/S
P/S
Price to Sales
4.9
vs History
94
vs Industry
27
Median 3Y
10.9
Median 5Y
12.6
Industry
2.4
Forward
4
More Details
Negative
P/E
P/E
Price to Earnings
N/A
vs History
vs Industry
1
Median 3Y
-173.8
Median 5Y
-105.8
Industry
23.2
Forward
-74.4
More Details
66.9
P/OCF
P/OCF
Price to OCF
66.9
vs History
62
vs Industry
4
Median 3Y
107.6
Median 5Y
107.6
Industry
15.5
More Details
80.7
P/FCFE
P/FCFE
Price to FCFE
80.7
vs History
28
vs Industry
7
Median 3Y
-210
Median 5Y
-194
Industry
23.5
More Details
5.2
P/B
P/B
Price to Book Value
5.2
vs History
94
vs Industry
15
Median 3Y
8.8
Median 5Y
10.2
Industry
2.2
More Details
4.6
EV/S
EV/S
Enterprise Value to Sales
4.6
vs History
94
vs Industry
25
Median 3Y
9.9
Median 5Y
11.6
Industry
2.5
Forward
3.8
More Details
5.3
EV/GP
EV/GP
Enterprise Value to Gross Profit
5.3
vs History
94
vs Industry
41
Median 3Y
11.1
Median 5Y
13
Industry
5.2
More Details
702.1
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
702.1
vs History
14
vs Industry
0
Median 3Y
156.7
Median 5Y
206
Industry
12.5
Forward
-117.2
More Details
Negative
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
N/A
vs History
vs Industry
2
Median 3Y
-129.1
Median 5Y
-105.5
Industry
17.2
Forward
-57.7
More Details
63.7
EV/OCF
EV/OCF
Enterprise Value to OCF
63.7
vs History
62
vs Industry
4
Median 3Y
101.2
Median 5Y
101.2
Industry
15.1
More Details
77
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
77
vs History
31
vs Industry
5
Median 3Y
-129.8
Median 5Y
-204.5
Industry
19.7
More Details
4.2
EV/IC
EV/IC
Enterprise Value to IC
4.2
vs History
94
vs Industry
20
Median 3Y
22
Median 5Y
26.2
Industry
2
More Details

Multiples Across Competitors

NARI Competitors Multiples
Inari Medical Inc Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
US
Inari Medical Inc
NASDAQ:NARI
2.4B USD 4.9 -1 468.8 702.1 -629.8
US
Abbott Laboratories
NYSE:ABT
184.3B USD 4.6 32.7 19.3 28.7
US
Intuitive Surgical Inc
NASDAQ:ISRG
131.8B USD 18 66.3 54.4 68.2
US
Stryker Corp
NYSE:SYK
124.8B USD 6 37.1 24.1 29.7
IE
Medtronic PLC
NYSE:MDT
107.6B USD 3.3 25.6 13.6 19.3
US
Boston Scientific Corp
NYSE:BSX
105.8B USD 7.2 59.9 30.6 45.1
US
Becton Dickinson and Co
NYSE:BDX
67.5B USD 3.5 55.4 18.6 39.2
DE
Siemens Healthineers AG
XETRA:SHL
57.5B EUR 2.6 37.9 18.2 30.7
CN
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
368.4B CNY 10.7 32.5 28.3 28.3
US
Edwards Lifesciences Corp
NYSE:EW
50.7B USD 8.3 35.9 26.1 28.2
US
Dexcom Inc
NASDAQ:DXCM
49.9B USD 13.1 78 58.3 75.9

See Also

Summary
NARI intrinsic value, competitors valuation, and company profile.
DCF Valuation
NARI stock valuation using Discount Cash Flow valuation method.
Relative Valuation
NARI stock valuation using valuation multiples.
Wall Street Estimates
NARI price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
NARI stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Join more than 133,400+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.